captopril has been researched along with Aura in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Dong, X; Fan, J; Gong, L; He, D; Jiang, J; Jiang, P; Kuang, H; Kuang, R; Lin, D; Shen, W; Wang, X; Xia, N; Xie, Y; Zeng, L | 1 |
1 other study(ies) available for captopril and Aura
| Article | Year |
|---|---|
Captopril alleviates epilepsy and cognitive impairment by attenuation of C3-mediated inflammation and synaptic phagocytosis.
Topics: Animals; Captopril; Cognitive Dysfunction; Epilepsy; Inflammation; Kainic Acid; Phagocytosis; Rats; Rats, Sprague-Dawley | 2022 |